Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation

Published:2010-08-20 Issue:3 Volume:26 Page:955-963
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Koc M.,Toprak A.,Arikan H.,Odabasi Z.,Elbir Y.,Tulunay A.,Asicioglu E.,Eksioglu-Demiralp E.,Glorieux G.,Vanholder R.,Akoglu E.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/26/3/955/5200487/gfq500.pdf

Reference34 articles.

1. Inflammation, Malnutrition, and Cardiac Disease as Predictors of Mortality in Hemodialysis Patients

2. Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy

3. In vivo induction of interleukin-1 during hemodialysis

4. Toll-like receptor–mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity

5. Toll-like receptor signalling

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revitalizing the Gut Microbiome in Chronic Kidney Disease: A Comprehensive Exploration of the Therapeutic Potential of Physical Activity;Toxins;2024-05-26

2. Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes;Science Translational Medicine;2024-05-22

3. Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine;eLife;2024-04-24

4. Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers – Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer;Pharmacology & Therapeutics;2024-03

5. The role of innate immunity in diabetic nephropathy and their therapeutic consequences;Journal of Pharmaceutical Analysis;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3